Erin Schenk, MD, PhD, discusses the importance of investigating novel targets and pathways in lung cancer.
Erin Schenk, MD, PhD
Advertisement
Articles by Erin Schenk, MD, PhD
Erin Schenk, MD, PhD, discusses the rapidly evolving treatment landscape in lung cancer.
Advertisement
Latest Updated Articles
Dr. Schenk on the Evolving Treatment Landscape in Lung CancerPublished: August 25th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5